The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia

被引:61
作者
Lawford, BR
Young, RM
Swagell, CD
Barnes, M
Burton, SC
Ward, WK
Heslop, KR
Shadforth, S
van Daal, A
Morris, CP
机构
[1] Royal Brisbane & Womens Hosp, Div Mental Hlth, Brisbane, Qld 4029, Australia
[2] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4072, Australia
[3] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4034, Australia
[4] Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4000, Australia
[5] Greenslopes Private Hosp, Greenslopes 4120, Australia
关键词
association; dopamine; D2; receptor; genetic; schizophrenia; C957T;
D O I
10.1016/j.schres.2004.08.020
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The T allele of the human dopamine D2 receptor (DRD2) gene C957T polymorphism is associated with reduced mRNA translation and stability. This results in decreased dopamine induced DRD2 upregulation and decreased in vivo D2 dopamine binding. Conversely, the C allele of the C957T polymorphism is not associated with such changes in mRNA leading to increased DRD2 expression. PET and postmortem binding studies show that schizophrenia is often associated with increased DRD2 availability. We report that on the basis of comparing the frequencies of the C/C and T/T genotypes of 153 patients with schizophrenia and 148 controls that schizophrenia is associated with the C/C genotype. The C957T shows a population attributable risk for schizophrenia of 24% and an attributable risk in those with schizophrenia of 42%. Increased expression of D2 receptors associated with the C allele is likely to be important in the underlying pathophysiology of at least some forms of schizophrenia. Enhanced understanding of schizophrenia afforded by this finding may lead to advances in treatment and prevention. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 40 条
[1]   Increased baseline occupancy of D2 receptors by dopamine in schizophrenia [J].
Abi-Dargham, A ;
Rodenhiser, J ;
Printz, D ;
Zea-Ponce, Y ;
Gil, R ;
Kegeles, LS ;
Weiss, R ;
Cooper, TB ;
Mann, JJ ;
Van Heertum, RL ;
Gorman, JM ;
Laruelle, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :8104-8109
[2]  
Abramson J. H., 2001, COMPUTER PROGRAMS EP
[3]   A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia [J].
Arinami, T ;
Gao, M ;
Hamaguchi, H ;
Toru, M .
HUMAN MOLECULAR GENETICS, 1997, 6 (04) :577-582
[4]   ASSOCIATION OF DOPAMINE D2 RECEPTOR MOLECULAR VARIANT WITH SCHIZOPHRENIA [J].
ARINAMI, T ;
ITOKAWA, M ;
ENGUCHI, H ;
TAGAYA, H ;
YANO, S ;
SHIMIZU, H ;
HAMAGUCHI, H ;
TORU, M .
LANCET, 1994, 343 (8899) :703-704
[5]  
Breen G, 1999, AM J MED GENET, V88, P407, DOI 10.1002/(SICI)1096-8628(19990820)88:4<407::AID-AJMG19>3.0.CO
[6]  
2-3
[7]   Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia [J].
Callicott, JH ;
Egan, MF ;
Mattay, VS ;
Bertolino, A ;
Bone, AD ;
Verchinksi, B ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04) :709-719
[8]  
Cohen J., 1988, STAT POWER ANAL BEHA
[9]   Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor [J].
Duan, JB ;
Wainwright, MS ;
Comeron, JM ;
Saitou, N ;
Sanders, AR ;
Gelernter, J ;
Gejman, PV .
HUMAN MOLECULAR GENETICS, 2003, 12 (03) :205-216
[10]   The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia [J].
Dubertret, C ;
Gouya, L ;
Hanoun, N ;
Deybach, JC ;
Adès, J ;
Hamon, M ;
Gorwood, P .
SCHIZOPHRENIA RESEARCH, 2004, 67 (01) :75-85